Research progress in impurity control of ursodeoxycholic acid

SUN Xuelin; XU Wenfeng; HU Xin

doi:10.6039/j.issn.1001-0408.2022.21.22

您当前的位置：

首页 >

文章列表页 >

Research progress in impurity control of ursodeoxycholic acid

更新时间：2023-02-22

- Research progress in impurity control of ursodeoxycholic acid
- ZHONGGUO YAOFANG Vol. 33, Issue 21, Pages: 2681-2684(2022)
- 作者机构：
  
  1.北京医院药学部，北京;100730
  2.国家老年医学中心/中国医学科学院老年医学研究院，北京　100730
  3.北京市药物临床风险与个体化应用评价重点实验室（北京医院），北京　100730
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2022.21.22
  CLC： R917
- Published：15 November 2022，
  
  Received：19 April 2022，
  
  Revised：22 September 2022，
扫描看全文
孙雪林,徐文峰,胡欣.熊去氧胆酸的杂质控制研究进展 ^Δ[J].中国药房,2022,33(21):2681-2684.

SUN Xuelin,XU Wenfeng,HU Xin.Research progress in impurity control of ursodeoxycholic acid[J].ZHONGGUO YAOFANG,2022,33(21):2681-2684.
孙雪林,徐文峰,胡欣.熊去氧胆酸的杂质控制研究进展 ^Δ[J].中国药房,2022,33(21):2681-2684. DOI： 10.6039/j.issn.1001-0408.2022.21.22.

SUN Xuelin,XU Wenfeng,HU Xin.Research progress in impurity control of ursodeoxycholic acid[J].ZHONGGUO YAOFANG,2022,33(21):2681-2684. DOI： 10.6039/j.issn.1001-0408.2022.21.22.

摘要

熊去氧胆酸（UDCA）是由胆固醇衍生而来的天然亲水性胆汁酸，在人体中含量较低，可用于治疗胆结石、胆汁淤积性肝病、脂肪肝等。由于国内外UDCA的合成工艺、原料药来源及杂质控制标准存在差异，因此，笔者通过查询相关文献总结UDCA在国内外的合成工艺，分析其原料药杂质来源及杂质控制标准。结果发现，美国、英国和欧洲的药典对UDCA的合成路线和杂质控制提出了明确的要求，并且制定了相应杂质控制标准；但是国内关于UDCA的合成工艺和杂质控制标准均较为简单。建议国内研究机构不断完善UDCA杂质谱，改进其合成工艺，提高其质量标准，为其进一步的药学研究和临床合理应用提供参考。

Abstract

Ursodeoxycholic acid （UDCA） is a natural hydrophilic bile acid derived from cholesterol， which has a low content in human body， and can be used for the treatment of gallstones， cholestatic liver disease， fatty liver and so on. Due to the differences in the synthesis process， source of active pharmaceutical ingredients （API） and impurity control standards of UDCA at home and abroad， the author summarized the synthesis process of UDCA at home and abroad by searching relevant literature， and analyzed the impurity sources and impurity control standards of API. The results showed that the pharmacopoeia of the United States， the United Kingdom and Europe put forward clear requirements on the synthesis route and impurity control of UDCA， and formulated corresponding impurity control standards. However， synthesis process and impurity detection standards of UDCA were relatively simple in China. It is suggested that domestic research institutions constantly improve impurity spectrum， promote the synthesis process， and improve the quality detection standards of UDCA， so as to provide a reference for pharmaceutical study and reasonable clinical application of UDCA.

关键词

熊去氧胆酸化学合成杂质质量控制

Keywords

chemical synthesisimpuritiesquality control

references

尤梅桂. 熊去氧胆酸的研究概况[J]. 药学研究，2021，40（3）：199-202.

张宗磊，付丙月，孔祥雨，等. 熊去氧胆酸合成工艺研究[J]. 中国药物化学杂志，2021，31（8）：593-596.

刘直. 熊去氧胆酸制备方法的进展[J]. 中国药学杂志，1988，23（10）：583-586.

郭梦芹，张艺铭，王洪璐，等. 鹅去氧胆酸合成熊去氧胆酸的研究进展[J]. 中国新药杂志，2020，29（20）：2358-2363.

冯娜. 鸭胆膏中鹅去氧胆酸提取及熊去氧胆酸合成[D]. 天津：天津科技大学，2018.

MASIHIKO H，KAZUHIRO M，TOMIO S. Selective reduction of 7-keto bile acids：JP6532692 [P]. 1993-02-10.

张国明，余晓岚，严崇萍. NBS氧化制备熊去氧胆酸中间体7-氧代石胆酸[J]. 中国医药工业杂志，1996，27（5）：234.

秦和平，张和平，钟义华，等. 一种酶促法合成熊去氧胆酸的方法：CN108251491A[P]. 2018-07-06.

刘红. 牛羊胆汁（膏）的质量控制[J]. 中药通报，1984，9（1）：24-25.

张启明，吴健敏，严克东，等. 牛胆粉和羊胆粉中胆汁酸的含量测定[J]. 中国生化药物杂志，1993，13（2）：44-46.

张启明. 牛胆粉的化学研究[J]. 药物生物技术，1997，4（1）：58-60.

王刚，操复川，李玲. 人工培育羊胆结石主要化学成分的研究[J]. 现代中药研究与实践，2007，21（2）：28-30.

YEH Y H，HWANG D F. High-performance liquid chromatographic determination for bile components in fish，chicken and duck[J]. J Chromatogr B Biomed Sci Appl，2001，751（1）：1-8.

KLINOT J，JIRSA M，KLINOTOVÁ E，et al. Isolation of （23R） 3α，7α，23-trihydroxy-5β-cholan-24-oic （β-phocaecholic） acid from duck bile. 1H NMR spectra of its derivatives[J]. Collect Czech Chem Commun，1986，51（8）：1722-1730.

ELKIN R G，WOOD K V，HAGEY L R. Biliary bile acid profiles of domestic fowl as determined by high performance liquid chromatography and fast atom bombardment mass spectrometry[J]. Comp Biochem Physiol B，1990，96（1）：157-161.

臧臻臻. 鸡胆汁中鹅去氧胆酸的提取及熊去氧胆酸合成[D]. 天津：天津科技大学，2017.

JIRSA M，KLINOT J，KLINOTOVÁ E，et al. Classical bile acids in animals，beta-phocaecholic acid in ducks[J]. Comp Biochem Physiol B，1989，92（2）：357-360.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Extraction， isolation， identification and content determination of four chemical components in Yao medicine Ventilago leiocarpa

Study on quality control method of the roots and rhizoma of Toricellia angulata

Identification of components， fingerprint and content determination of the effective parts of Dracocephalum moldavica

Study on quality control method of Qiguiling mixture

Quality control of the technology method of clinical comprehensive drug evaluation

Related Author

XIA Xueqing

HUANG Jianyou

HUANG Zhoufeng

GAO Meimei

HUANG Hongmiao

LU Guoshou

LI Xue

NIE Yushan

Related Institution

College of Pharmacy， Guangxi University of Chinese Medicine

Guangxi Zhuang Autonomous Region Institute of Traditional Medical and Pharmaceutical Sciences

Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards

Engineering Research Center for the Development and Application of Ethnic Medicine and TCM/State Key Laboratory of Functions and Applications of Medicinal Plants， Guizhou Medical University

School of Pharmacy， Guizhou Medical University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰